Table 5 |
|||
|
Changes in 6 MWD Between and Within Groups Over 12 weeks of treatment. |
|||
|
Variable |
Baseline 6 MWD |
End 6 MWD |
Baseline-End 6 MWD |
|
|
|||
|
PBO |
1323.4 |
1331.9 |
-8.4 |
|
SD |
226.1 |
250.2 |
109.3 |
|
Sig.* |
NS |
||
|
A |
1427.5 |
1528.8 |
-101.3 |
|
SD |
225.6 |
252.3 |
121.5 |
|
Sig.* |
0.001 |
||
|
GS |
1410.1 |
1456.8 |
-55.7 |
|
SD |
246.1 |
256.1 |
103 |
|
Sig.* |
0.03 |
||
|
G+A |
1363.1 |
1378.1 |
-15 |
|
SD |
253.7 |
253 |
126.6 |
|
Sig.* |
NS |
||
|
p (ANCOVA) |
NS |
||
|
|
|||
|
*Sig. = significance by within group paired t-test; 2-tailed; ANCOVA comparison between groups with baseline measure as covariate |
|||
|
Frestedt et al. Nutrition Journal 2008 7:9 doi:10.1186/1475-2891-7-9 |
|||
